Assembly Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Assembly Biosciences, Inc. (ASMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 384.70 thousand shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-04.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-03-04
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 384.70K shares.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2013 was 69.98K shares, a 83.55% decline from fiscal 2012.
- Assembly Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2012 was 425.48K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|
| 2019-12-31 | 384.70K shares 10-K · filed 2020-03-04 | |
| 2014-07-10 | 514.45K shares 10-K · filed 2015-03-16 | |
| 2013-12-31 | 69.98K shares 10-K · filed 2014-03-31 | |
| 2012-12-31 | 425.48K shares 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |